| SC 13G/A | 2023-02-14 | Vivo Panda, LLC | Aadi Bioscience, Inc. | 509,572 | 2.1% | EDGAR |
| SC 13G/A | 2023-02-10 | Satter Muneer A | Aadi Bioscience, Inc. | 1,630,830 | 6.7% | EDGAR |
| SC 13D/A | 2023-01-17 | Desai Neil | Aadi Bioscience, Inc. | 2,635,196 | 10.8% | EDGAR |
| SC 13G | 2022-10-04 | Satter Muneer A | Aadi Bioscience, Inc. | 1,294,785 | 5.3% | EDGAR |
| SC 13D/A | 2022-09-26 | Avoro Capital Advisors LLC | Aadi Bioscience, Inc. | 2,849,402 | 11.7% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Aadi Bioscience, Inc. | 465,262 | 2.2% | EDGAR |
| SC 13G | 2022-02-14 | Venrock Healthcare Capital Partners II, L.P. | Aadi Bioscience, Inc. | 1,529,402 | 7.3% | EDGAR |
| SC 13G/A | 2022-02-11 | Vivo Panda, LLC | Aadi Bioscience, Inc. | 575,723 | 2.8% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | Aadi Bioscience, Inc. | 761,473 | 3.6% | EDGAR |
| SC 13G/A | 2021-11-15 | RA CAPITAL MANAGEMENT, L.P. | Aadi Bioscience, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2021-11-12 | Satter Muneer A | Aadi Bioscience, Inc. | 374,785 | 1.8% | EDGAR |
| SC 13D | 2021-09-08 | Desai Neil | Aadi Bioscience, Inc. | 2,598,441 | 12.4% | EDGAR |
| SC 13D | 2021-09-07 | ACUTA CAPITAL PARTNERS, LLC | Aadi Bioscience, Inc. | 1,529,402 | 7.2% | EDGAR |
| SC 13G | 2021-09-07 | BIOTECHNOLOGY VALUE FUND L P | Aadi Bioscience, Inc. | 607,164 | 2.9% | EDGAR |
| SC 13D/A | 2021-09-03 | ORBIMED ADVISORS LLC | Aadi Bioscience, Inc. | 346,262 | 1.7% | EDGAR |
| SC 13G | 2021-09-02 | Vivo Panda, LLC | Aadi Bioscience, Inc. | 586,042 | 2.8% | EDGAR |
| SC 13D/A | 2021-08-30 | Avoro Capital Advisors LLC | Aadi Bioscience, Inc. | 1,829,402 | 8.8% | EDGAR |
| SC 13G | 2021-08-23 | RA CAPITAL MANAGEMENT, L.P. | Aerpio Pharmaceuticals, Inc. | 2,486,242 | 5.2% | EDGAR |
| SC 13G | 2021-07-12 | RA CAPITAL MANAGEMENT, L.P. | Aerpio Pharmaceuticals, Inc. | 1,574,806 | 3.3% | EDGAR |
| SC 13D | 2021-06-04 | Avoro Capital Advisors LLC | Aerpio Pharmaceuticals, Inc. | 4,500,000 | 9.5% | EDGAR |